Auro Laboratories share news, announcements and annual reports
BSE: 530233Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹232.75.
30 Oct: open ₹234.00, high ₹234.00, low ₹225.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹145 Cr2,545th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 30.97
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.13
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 10.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 8.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 1.37
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 648
Auro Laboratories share news and announcements
443 announcements, routine notices left out, newest first. Page 6 of 9.
Jun 2020
23 Jun · Board meeting
Meeting on 29 Jun 2020: audited results17 Jun · Legal
Exchange has sought clarification from Auro Laboratories Ltd on June 17, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Apr 2020
29 Apr · Compliance Certificate For The Period Ended March 31, 2020 Under Regulation 7(3) Of SEBI (LODR), 2015
28 Apr · Compliance Certificate Under Regulation 40(9) Of The SEBI Listing Regulations, 2015 For The Half Year Ended March 31, 2020
23 Apr · Legal
Exchange has sought clarification from Auro Laboratories Ltd on April 23, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant ....18 Apr · Shareholding for the Period Ended March 31, 2020
Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click ....10 Apr · Statement Of Investor Complaints For The Quarter Ended March 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Feb 2020
Jan 2020
24 Jan · Board meeting
Meeting on 4 Feb 2020: quarterly results14 Jan · Shareholding for the Period Ended December 31, 2019
Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click ....9 Jan · Statement Of Investor Complaints For The Quarter Ended December 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Nov 2019
15 Nov · Disclosure Of Related Party Transactions Under Regulation 23(9) Of SEBI(LODR)Regulations, 2015 For The Half Year Ended September 30, 2019
Oct 2019
18 Oct · Certificate Under Regulation 40(9) Of The SEBI (LODR) Regulations, 2015
16 Oct · Shareholding for the Period Ended September 30, 2019
Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click ....16 Oct · Compliance Certificate Under Regulation 7(3) Of The SEBI (LODR) Regulations, 2015 For The Half Year Ended September 30, 2019
9 Oct · Board meeting
Meeting on 22 Oct 2019: quarterly results9 Oct · Statement Of Investor Complaints For The Quarter Ended September 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Sep 2019
9 Sep · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Aug 2019
9 Aug · Reg. 34 (1) Annual Report
Jul 2019
25 Jul · Board meeting
Meeting on 7 Aug 2019: quarterly results22 Jul · Shareholding for the Period Ended June 30, 2019
Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click ....10 Jul · Statement Of Investor Complaints For The Quarter Ended June 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Jun 2019
10 Jun · Non-Applicability Of Regulation 23(9) Of The SEBI (LODR) Regulations, 2015 - Disclosure Of Related Party Transactions.
May 2019
23 May · Board meeting
14 May · Board meeting
Meeting on 23 May 2019: audited results
Apr 2019
23 Apr · Certificate Under Regulation 40(9) Of The SEBI (LODR) Regulations, 2015
17 Apr · Compliance Certificate Under Regulation 7(3) Of The SEBI (LODR) Regulations, 2015 For The Half Year Ended March 31, 2019
11 Apr · Shareholding for the Period Ended March 31, 2019
Shareholding Pattern for the Period Ended March 31, 2019. For more details, kindly Click ....11 Apr · Statement Of Investor Complaints For The Quarter Ended March 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Mar 2019
30 Mar · Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Feb 2019
Jan 2019